Xithelia Nova Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 12-01-2025
- Paid Up Capital ₹ 0.10 M
as on 12-01-2025
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 13.36%
(FY 2022)
- Profit 7.42%
(FY 2022)
- Ebitda 13.79%
(FY 2022)
- Net Worth -44.53%
(FY 2022)
- Total Assets 39.75%
(FY 2022)
About Xithelia Nova Healthcare
The Corporate was formerly known as Blubug Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Gupta, Adeep Gupta, and Poonam Gupta serve as directors at the Company.
- CIN/LLPIN
U74120MH2015PTC270592
- Company No.
270592
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Dec 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Xithelia Nova Healthcare Private Limited offer?
Xithelia Nova Healthcare Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Anti Ulcer Drugs.
Who are the key members and board of directors at Xithelia Nova Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Gupta  | Director | 21-Mar-2016 | Current |
| Adeep Gupta | Director | 01-Dec-2015 | Current |
| Poonam Gupta | Director | 01-Dec-2015 | Current |
Financial Performance of Xithelia Nova Healthcare.
Xithelia Nova Healthcare Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.36% increase. The company also saw a slight improvement in profitability, with a 7.42% increase in profit. The company's net worth observed a substantial decline by a decrease of 44.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xithelia Nova Healthcare?
In 2021, Xithelia Nova Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Xithelia Nova Healthcare?
Unlock and access historical data on people associated with Xithelia Nova Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xithelia Nova Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xithelia Nova Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
